American Psychiatric Association Publishing is the world’s premier publisher of books, journals, and multimedia on psychiatry, mental health, and behavioural science. We offer authoritative, up-to-date, and affordable information geared toward psychiatrists, other mental health professionals, psychiatric residents, medical students, and the general public.
APA Publishing is a division of the American Psychiatric Association. Its purpose is twofold: to serve as the distributor of publications of the Association and to publish books independent of the policies and procedures of the American Psychiatric Association. APA Publishing has grown since its founding in 1981 into a full-service publishing house, including a staff of editorial, production, marketing, and business experts devoted to publishing for the field of psychiatry and mental health.
This compelling new guide calls for an expanded definition, one that involves the persistent fears and shame of individuals related to what others might think of them if certain actions or thoughts in their past or present were ever to become known-even when there may be no actual interaction with those other people.
The Story of Modern Psychiatry's Most Fascinating Molecule
Few substances are as enigmatic as ketamine. Is it an effective anesthetic? A useful tool for the psychiatrist? A doorway to transcendence and spiritual awakening? A dangerously addictive drug? The opinions are as plentiful as the individuals who encounter it. As its use in the psychiatric setting expands.
The Anxiety and Depression Association of America (ADAA) and the American Psychiatric Association (APA) have collaborated on this comprehensive guide, which is designed to empower patients and their support networks in their quest for wellness. Structured into six sections, each offering invaluable insights and tools.
By 2050, 85.7 million people in the United States are projected to be 65 or older. Older adults are especially prone to the effects of substances, and a 2021 survey showed that 4 million older adults were dealing with a substance use disorder. As the country's population ages, clinicians will inevitably have to care for a greater number of older ......
Recent studies suggest that anywhere from 20% to as much as 60% of psychiatric diagnoses are eventually labeled as treatment resistant. No consensus exists on a definition for treatment resistance, nor are there clear criteria for what is still an unrecognized diagnosis, which suggests that incomplete assessments, inadequate treatment planning, ......
A seminal resource since the first edition was published in 1986, Schatzbergs Manual of Clinical Psychopharmacology has distinguished itself, from the very beginning, for its readability and comprehensive approach to the field. This tenth edition builds on that legacy, providing a thorough understanding of evolving treatments and medications
Now in its sixth edition, The American Psychiatric Association Publishing Textbook of Psychopharmacology remains the field's most comprehensive guide to the theory and practice of psychopharmacology. This extensively updated new edition features the expertise of more than 160 contributors, including more than 75 new authors. Twelve new chapters ......
The DSM-5-TR Handbook of Differential Diagnosis is the preeminent guide to differential diagnosis for both clinicians and students learning psychiatric diagnosis. Fully updated to reflect the recent Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), it offers a rich selection of diagnostic lenses ......
